Double Medical Technology Inc
Double Medical Technology Inc maintains a strong liquidity position with a current ratio of 3.8, indicating the company can cover its short-term liabilities more than three times over. However, the company's cash and equivalents of CNY 4,997,830 are significantly lower than its long-term debt of CNY 315,869,160, resulting in a net cash position that is negative after subtracting total debt. This suggests potential liquidity risk if the company faces unexpected cash outflows or if its operating cash flow does not meet expectations. The company's profitability is robust, with a return on equity (ROE) of 16.8% and a return on assets (ROA) of 12.18%, both exceeding the typical thresholds for strong performance in the medical equipment industry. The gross profit margin of 68.2% (CNY 1,774,706,490 on CNY 2,600,859,750 revenue) and an operating margin of 28.3% (CNY 737,297,850) further support its strong profitability. These metrics suggest the company is effectively managing its costs and generating healthy returns on its operations. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of geographic segmentation may expose the company to regional economic or regulatory risks, particularly if its operations are heavily concentrated in one market. The company's growth trajectory is positive, with a strong operating cash flow of CNY 831,337,040 and a free cash flow of CNY 425,652,810, indicating the ability to fund operations and potentially reinvest in the business. However, the capital expenditure of CNY -133,506,850 suggests a reduction in investment in new assets, which may impact long-term growth if not offset by other strategic initiatives. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The debt-to-equity ratio of 0.09 indicates a conservative capital structure with limited leverage. However, the negative net cash position after subtracting total debt raises concerns about the company's ability to meet long-term obligations without additional financing. The company's ESG score of 28.89 and a C- grade suggest room for improvement in environmental, social, and governance practices. Recent events, as reflected in the company's financial filings, show a consistent revenue and profit performance, with no significant one-time events or extraordinary items reported in the latest financial statements. The company's ESG controversies score of 100 indicates no major controversies, but the low ESG score suggests ongoing challenges in sustainability and governance.
Business. Double Medical Technology Inc is a medical equipment and supplies company that generates revenue primarily through the production and distribution of healthcare products.
Classification. The company is classified under the Healthcare Services & Equipment business sector within the Healthcare economic sector, with a classification confidence of 0.92.
- Double Medical Technology Inc has a strong profitability profile with ROE of 16.8% and ROA of 12.18%.
- The company's liquidity is robust with a current ratio of 3.8, but its net cash position is negative after subtracting total debt.
- The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- The company's ESG score of 28.89 and a C- grade indicate room for improvement in sustainability and governance practices.
- The company's capital expenditure is negative, suggesting a reduction in investment in new assets.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.